Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Oncol. 2007 Apr;34(2 Suppl 3):S4-9.

A pathologist's perspective on emerging genomic tests for breast cancer.

Author information

  • 1Department of Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA. fsymmans@mdanderson.org

Abstract

Emerging molecular tests for breast cancer indicate how future progress in diagnostic pathology might guide patient care. However, the challenge will be to bring the best results from this exciting research into clinical use as accurate and reliable standardized tests that integrate into the diagnostic work-up.

PMID:
17512433
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk